Beniflip T Tablet is a combination of Benidipine (4 mg) and Telmisartan (40 mg), designed for the effective management of hypertension (high blood pressure) and cardiovascular conditions. This combination provides a dual-action approach to lowering blood pressure, reducing the risk of heart-related complications such as heart attacks, strokes, and kidney diseases.
Benidipine, a calcium channel blocker (CCB), works by relaxing blood vessels, improving blood flow, and reducing the workload on the heart. It helps maintain stable blood pressure levels throughout the day and has additional protective effects on the kidneys and heart.
Telmisartan, an angiotensin II receptor blocker (ARB), prevents the constriction of blood vessels, further promoting relaxation and reducing blood pressure. It also provides renal protection, making it particularly beneficial for patients with hypertension-related kidney conditions or diabetes.
Together, Benidipine and Telmisartan provide superior blood pressure control compared to monotherapy, making Beniflip T Tablet an ideal choice for patients with moderate to severe hypertension or those requiring additional blood pressure regulation. The combination also helps in the prevention of cardiovascular events, improving overall heart health.
Beniflip T Tablet is usually well-tolerated and may be prescribed as a first-line or adjunct therapy for hypertension. Regular use as directed by a healthcare professional ensures optimal cardiovascular protection.